Yttrium-90 radioembolization for the treatment of unresectable hepatocellular carcinoma in patients with transjugular intrahepatic portosystemic shunts.


PURPOSE To evaluate the toxicity and response to radioembolization with yttrium-90 ((90)Y) glass microspheres in patients with hepatocellular carcinoma (HCC) and existing transjugular intrahepatic portosystemic shunts (TIPS). MATERIALS AND METHODS For treatment of unresectable HCC, 12 patients with a patent TIPS underwent a total of 21 infusions of (90)Y… (More)
DOI: 10.1016/j.jvir.2012.09.030


7 Figures and Tables